Description

1,5-Methano-2H-Pyrido[1,2-A][1,5]Diazocine,3-Ethyldecahydro-,(1R,5S,11As)-(9Ci) is a complex, stereochemically defined heterocyclic compound with the CAS number 760976-15-6. This structurally unique molecule serves as a high-value advanced intermediate or building block in sophisticated organic synthesis. It is primarily required by pharmaceutical R&D and fine chemical manufacturers for the development of novel active ingredients and complex molecular architectures.

Application

• Pharmaceutical Intermediate: A key chiral building block for the synthesis of novel drug candidates, particularly in central nervous system (CNS) and antiviral research.
• Asymmetric Synthesis: Utilized in the construction of complex, stereochemically pure molecules due to its defined (1R,5S,11As) configuration.
• Medicinal Chemistry Research: Serves as a core scaffold for structure-activity relationship (SAR) studies and library synthesis in drug discovery programs.
• Fine Chemical Production: Employed in the multi-step synthesis of specialty chemicals, agrochemicals, and high-performance materials.
• Academic & Institutional Research: Used in universities and research institutes for methodological development in organic and heterocyclic chemistry.
• Catalyst & Ligand Development: Potential precursor for novel chiral catalysts or ligands used in enantioselective transformations.

Basic Information

Product Name	1,5-Methano-2H-Pyrido[1,2-A][1,5]Diazocine,3-Ethyldecahydro-,(1R,5S,11As)-(9Ci)
CAS No.	760976-15-6
Molecular Formula	C14H24N2
Molecular Weight	220.35 g/mol
Synonyms	(1R,5S,11aS)-3-Ethyldecahydro-1,5-methano-2H-pyrido[1,2-a][1,5]diazocine; 3-Ethyldecahydro-1,5-methano-2H-pyrido[1,2-a][1,5]diazocine; 760976-15-6; (1R,5S,11aS)-3-Ethyl-1,5-methano-2H-pyrido[1,2-a][1,5]diazocine; Decahydro-3-ethyl-1,5-methano-2H-pyrido[1,2-a][1,5]diazocine; (1R,5S,11aS)-3-Ethyldecahydro-1,5-methanopyrido[1,2-a][1,5]diazocine
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Each batch undergoes comprehensive analytical characterization, including chiral purity verification, to ensure identity, strength, and composition. Certificates of Analysis (COA) detailing specifications such as assay (HPLC), enantiomeric excess, and impurity profiles are provided. We support development and cGMP-grade requirements for pharmaceutical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The compound may be hygroscopic; keep the container tightly sealed under an inert atmosphere if specified. Keep away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Chiral Purity (Chiral HPLC)	≥ 98.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.